Antifungal Locks to Treat Fungal-related Central Line Infections

NCT00936910 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Central Line Fungal Infections

Interventions

DRUG: amphotericin B liposomal (Ambisome)

Sponsor

Bill McGhee

Collaborators

[object Object]